Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes

Neuroscience Research

Volumn 55, Issue 4, 2006, Pages 352-360

  Iwai, Takashi ^a   Ito, Satoshi ^a   Tanimitsu, Kahori ^a   Udagawa, Shunichi ^a   Oka, Jun Ichiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Astrocyte; cAMP; Glucagon like peptide 1; Interleukin 1 ; Lipopolysaccharide; Microglia

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE INHIBITOR; BINDING PROTEIN; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREACTIVITY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ADENYLATE CYCLASE; ANIMALS; ASTROCYTES; BRAIN; CELL SHAPE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENCEPHALITIS; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICROGLIA; PHOSPHORYLATION; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; RNA, MESSENGER; UP-REGULATION;

EID: 33744996917     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.04.008     Document Type: Article

References (31)

1. Aschner M., Allen J.W., Kimelberg H.K., LoPachin R.M., and Streit WJ. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 151-173
2. Banati R.B., Gehrmann J., Schubert P., and Kreutzberg GW. Cytotoxicity of microglia. Glia 7 (1993) 111-118
3. Barres B.A., and Barde Y. Neuronal and glial cell biology. Curr. Opin. Neurobiol. 10 (2000) 642-648
4. Bruce-Keller A.J. Microglial-neuronal interactions in synaptic damage and recovery. J. Neurosci. Res. 58 (1999) 191-201
5. Cacabelos R., Alvarez X.A., Fernández-Novoa L., Franco A., Mangues R., Pellicer A., and Nishimura T. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp. Clin Pharmacol. 16 (1994) 141-151
6. Campos R.V., Lee Y.C., and Drucker D.J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134 (1994) 2156-2164
7. Chao C.C., Hu S., Ehrlich L., and Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 9 (1995) 355-365
8. Chung I.Y., and Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes: induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J. Immunol. 144 (1990) 2999-3007
9. Delgado M., Munoz-Elias E.J., Kan Y., Gozes I., Fridkin M., Brenneman D.E., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-κB and cAMP response element-binding protein/c-Jun. J. Biol. Chem. 273 (1998) 31427-31436
10. Göke R., Larsen P.J., Mikkelsen J.D., and Sheikh SP. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7 (1995) 2294-2300
11. Gonzalez G.A., Yamamoto K.K., Fischer W.H., Karr D., Menzel P., Biggs W., Vale W.W., and Montminy M.R. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 337 (1989) 749-752
12. Griffin W.S., and Mrak R.E. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 72 (2002) 233-238
13. Iwai T., Kondo Y., and Oka J-I. Effects of glucagon-like peptide-1 on LTP in β-amyloid protein (1-42)-treated hippocampal slices. Soc. Neurosci. Abstr. 26 (2000) 1116
14. Jhala U.S., Canettieri G., Screaton R.A., Kulkarni R.N., Krajewski S., Reed J., Walker J., Lin X., White M., and Montminy M. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17 (2003) 1575-1580
15. Kalla R., Bohatschek M., Kloss C.U.A., Krol J., Maltzan X.V., and Raivich G. Loss of microglial ramification in microglia-astrocyte cocultures: involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. Glia 41 (2003) 50-63
16. Kielian T. Immunopathogenesis of brain abscess. J. Neuroinflamm. 1 (2004) 16
17. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 932-940
18. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad Sci. U.S.A. 82 (1985) 4245-4249
19. McGeer P.L., Akiyama H., Itagaki S., and McGeer E.G. Immune response in Alzheimer's disease. Can. J. Neurol. Sci. 16 (1989) 516-527
20. Merchenthaler I., Lane M., and Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403 (1999) 261-280
21. Mojsov S., Heinrich G., Wilson I.B., Ravazzola M., Orci L., and Habener J.F. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 261 (1986) 11880-11889
22. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
23. Mrak R.E., and Griffin W.S. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol. Aging 22 (2001) 903-908
24. Oka J.-I., Goto N., and Kameyama T. Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus. Neuroreport 10 (1999) 1643-1646
25. Oka J.-I., Suzuki E., Goto N., and Kameyama T. Endogenous GLP-1 modulates hippocampal activity in β-amyloid protein-treated rats. Neuroreport 10 (1999) 2961-2964
26. Oka J.-I., Suzuki E., and Kondo Y. Behavioral studies indicate a role for glucagon-like peptide-1 in memory and learning in rat. Soc. Neurosci. Abstr. 25 (1862)
27. Oka J.-I., Suzuki E., and Kondo Y. Endogenous GLP-1 is involved in β-amyloid protein-induced memory impairment and hippocampal neuronal death in rats. Brain Res. 878 (2000) 194-198
28. Perez R.L., Ritzenthaler J.D., and Roman J. Transcriptional regulation of the interleukin-1β promoter via fibrinogen engagement of the CD18 integrin receptor. Am. J. Respir. Cell Mol. Biol. 20 (1999) 1059-1066
29. Stewart W.F., Kawas C., Corrada M., and Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48 (1997) 626-632
30. 2+ channel activity. Endocrinology 133 (1993) 1685-1692
31. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., and Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26 (1995) 676-680 (discussion 68)